HIPAA Business Associate agreements for custom model development

**HIPAA. BAA. Custom models. That’s the alphabet of enterprise credibility.** Cohere’s move to offer Business Associate agreements for bespoke model development isn’t a footnote—it’s a threshold. Healthcare runs on trust, and trust runs on verifiable compliance, not marketing decks. For an AI vendor to step into that arena without a BAA is like a surgeon showing up without scrubs. This is the sector saying: *custom AI is no longer a science project; it’s a clinical instrument.* What does this signal? That the competitive battlefield in AI is shifting from raw benchmark scores to *operational accountability*. The moat is no longer just model quality—it’s the ability to map every data flow, every token, every log to a legal promise. BAAs are just the start. Expect SOC 2 Type II, FedRAMP, and a stampede of enterprise-grade certifications as AI vendors realize that the CIO’s real question isn’t “How smart is it?” but “How safe is it with my crown jewels?” Custom model development is inherently high-touch, which means high-exposure. By offering a BAA, Cohere isn’t just checking a box—they’re building a scaffold for trust in a domain where the half-life of a breach is forever. Final thought: In healthcare AI, a model’s accuracy is worthless if its provenance isn’t bulletproof. Cohere just made trust a feature, not a footnote. {"key_insight":"Custom AI models demand bespoke compliance, turning BAAs into a strategic differentiator, not just legal overhead.","confidence":0.85}